These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 27909711)

  • 1. Effect of partial PEGylation on particle uptake by macrophages.
    Sanchez L; Yi Y; Yu Y
    Nanoscale; 2017 Jan; 9(1):288-297. PubMed ID: 27909711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage uptake of Janus particles depends upon Janus balance.
    Gao Y; Yu Y
    Langmuir; 2015 Mar; 31(9):2833-8. PubMed ID: 25674706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of particle geometry and PEGylation on phagocytosis of particulate carriers.
    Mathaes R; Winter G; Besheer A; Engert J
    Int J Pharm; 2014 Apr; 465(1-2):159-64. PubMed ID: 24560647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEGylation of model drug carriers enhances phagocytosis by primary human neutrophils.
    Kelley WJ; Fromen CA; Lopez-Cazares G; Eniola-Adefeso O
    Acta Biomater; 2018 Oct; 79():283-293. PubMed ID: 30195083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein corona components of polyethylene glycol-conjugated organosilica nanoparticles modulates macrophage uptake.
    Kim H; Röth D; Isoe Y; Hayashi K; Mochizuki C; Kalkum M; Nakamura M
    Colloids Surf B Biointerfaces; 2021 Mar; 199():111527. PubMed ID: 33387796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phagocytosis of crystalline silica particles by macrophages.
    Gilberti RM; Joshi GN; Knecht DA
    Am J Respir Cell Mol Biol; 2008 Nov; 39(5):619-27. PubMed ID: 18556590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoting the Delivery of Nanoparticles to Atherosclerotic Plaques by DNA Coating.
    Zhang L; Tian XY; Chan CKW; Bai Q; Cheng CK; Chen FM; Cheung MSH; Yin B; Yang H; Yung WY; Chen Z; Ding F; Leung KC; Zhang C; Huang Y; Lau JYW; Choi CHJ
    ACS Appl Mater Interfaces; 2019 Apr; 11(15):13888-13904. PubMed ID: 30516979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
    Parveen S; Sahoo SK
    Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tight nanoscale clustering of Fcγ receptors using DNA origami promotes phagocytosis.
    Kern N; Dong R; Douglas SM; Vale RD; Morrissey MA
    Elife; 2021 Jun; 10():. PubMed ID: 34080973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro macrophage uptake and in vivo biodistribution of PLA-PEG nanoparticles loaded with hemoglobin as blood substitutes: effect of PEG content.
    Sheng Y; Yuan Y; Liu C; Tao X; Shan X; Xu F
    J Mater Sci Mater Med; 2009 Sep; 20(9):1881-91. PubMed ID: 19365612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density.
    Vila A; Gill H; McCallion O; Alonso MJ
    J Control Release; 2004 Aug; 98(2):231-44. PubMed ID: 15262415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How half-coated janus particles enter cells.
    Gao Y; Yu Y
    J Am Chem Soc; 2013 Dec; 135(51):19091-4. PubMed ID: 24308498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEGylated PEI-based biodegradable polymers as non-viral gene vectors.
    Huang FW; Wang HY; Li C; Wang HF; Sun YX; Feng J; Zhang XZ; Zhuo RX
    Acta Biomater; 2010 Nov; 6(11):4285-95. PubMed ID: 20601231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding and uptake of single and dual-opsonized targets by macrophages.
    Naik U; Nguyen QPH; Harrison RE
    J Cell Biochem; 2020 Jan; 121(1):183-199. PubMed ID: 31172552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution and Cellular Uptake of PEGylated Polymeric Particles in the Lung Towards Cell-Specific Targeted Delivery.
    Shen TW; Fromen CA; Kai MP; Luft JC; Rahhal TB; Robbins GR; DeSimone JM
    Pharm Res; 2015 Oct; 32(10):3248-60. PubMed ID: 26002743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEGylated and CD47-conjugated nanoellipsoidal artificial antigen-presenting cells minimize phagocytosis and augment anti-tumor T-cell responses.
    Song S; Jin X; Zhang L; Zhao C; Ding Y; Ang Q; Khaidav O; Shen C
    Int J Nanomedicine; 2019; 14():2465-2483. PubMed ID: 31040669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes.
    Qie Y; Yuan H; von Roemeling CA; Chen Y; Liu X; Shih KD; Knight JA; Tun HW; Wharen RE; Jiang W; Kim BY
    Sci Rep; 2016 May; 6():26269. PubMed ID: 27197045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage phagocytosis assay with reconstituted target particles.
    Joffe AM; Bakalar MH; Fletcher DA
    Nat Protoc; 2020 Jul; 15(7):2230-2246. PubMed ID: 32561889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailored Dual PEGylation of Inorganic Porous Nanocarriers for Extremely Long Blood Circulation in Vivo.
    Nissinen T; Näkki S; Laakso H; Kučiauskas D; Kaupinis A; Kettunen MI; Liimatainen T; Hyvönen M; Valius M; Gröhn O; Lehto VP
    ACS Appl Mater Interfaces; 2016 Dec; 8(48):32723-32731. PubMed ID: 27934159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.